Journal for ImmunoTherapy of Cancer (Nov 2020)

605 Systemically administered HER2-targeted ISACs provoke a rapid, local response that engages the innate and adaptive arms of the immune system to eradicate tumors in preclinical models

  • Marcin Kowanetz,
  • Po Ho,
  • Shelley Ackerman,
  • Heidi LeBlanc,
  • David Dornan,
  • Michael Alonso,
  • Cecelia Pearson,
  • Andrew Luo,
  • Richard Laura,
  • Justin Kenkel,
  • LIsa Blum,
  • Angela Luo,
  • Matthew Zhou,
  • Joshua Gregorio,
  • Brian Safina

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0605
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.